Simulations Plus, Inc. (NASDAQ:SLP) Shares Acquired by InTrack Investment Management Inc

InTrack Investment Management Inc lifted its position in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 5.9% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 33,543 shares of the technology company’s stock after buying an additional 1,878 shares during the period. InTrack Investment Management Inc owned approximately 0.17% of Simulations Plus worth $1,074,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Azzad Asset Management Inc. ADV boosted its position in shares of Simulations Plus by 68.7% during the 3rd quarter. Azzad Asset Management Inc. ADV now owns 13,505 shares of the technology company’s stock worth $432,000 after purchasing an additional 5,498 shares during the period. The Manufacturers Life Insurance Company boosted its position in shares of Simulations Plus by 7.7% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 6,391 shares of the technology company’s stock worth $311,000 after purchasing an additional 456 shares during the period. Deerfield Management Company L.P. Series C purchased a new position in shares of Simulations Plus during the 2nd quarter worth approximately $811,000. Public Sector Pension Investment Board boosted its position in shares of Simulations Plus by 6.4% during the 2nd quarter. Public Sector Pension Investment Board now owns 35,227 shares of the technology company’s stock worth $1,713,000 after purchasing an additional 2,122 shares during the period. Finally, Dimensional Fund Advisors LP boosted its position in shares of Simulations Plus by 10.1% during the 2nd quarter. Dimensional Fund Advisors LP now owns 414,005 shares of the technology company’s stock worth $20,128,000 after purchasing an additional 37,992 shares during the period. Institutional investors and hedge funds own 78.08% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on SLP shares. JMP Securities started coverage on shares of Simulations Plus in a research report on Tuesday, July 16th. They set a “market perform” rating for the company. KeyCorp initiated coverage on shares of Simulations Plus in a research report on Monday, July 29th. They issued an “overweight” rating and a $47.00 price target for the company. William Blair reissued an “outperform” rating on shares of Simulations Plus in a research report on Thursday, September 12th. Finally, Craig Hallum reissued a “buy” rating and issued a $56.00 price target on shares of Simulations Plus in a research report on Wednesday, July 3rd. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $56.00.

Insider Transactions at Simulations Plus

In other news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $35.18, for a total transaction of $703,600.00. Following the completion of the sale, the director now directly owns 3,501,592 shares of the company’s stock, valued at approximately $123,186,006.56. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In the last three months, insiders sold 60,750 shares of company stock valued at $2,145,055. Insiders own 20.90% of the company’s stock.

Simulations Plus Stock Up 2.9 %

Shares of SLP stock opened at $31.24 on Friday. Simulations Plus, Inc. has a 52 week low of $29.37 and a 52 week high of $51.22. The stock has a market capitalization of $625.05 million, a PE ratio of 65.08 and a beta of 0.69. The firm has a 50 day moving average of $33.87 and a two-hundred day moving average of $41.32.

Simulations Plus Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.